SynopsisThe global market for Dupilumab Drug was valued at US$ 18570 million in the year 2024 and is projected to reach a revised size of US$ 36530 million by 2031, growing at a CAGR of 10.3% during the forecast period. Dupilumab is a fully human monoclonal anti.....
SynopsisThe global market for Enteral Feeding Devices was valued at US$ 3404 million in the year 2024 and is projected to reach a revised size of US$ 5316 million by 2031, growing at a CAGR of 6.7% during the forecast period. Enteral feeding device is a medical .....
SynopsisThe global market for Clear-Aligner Treatment was valued at US$ 5055 million in the year 2024 and is projected to reach a revised size of US$ 19630 million by 2031, growing at a CAGR of 21.7% during the forecast period. Clear-Aligner Treatment is orthodo.....
SynopsisThe global market for Lenalidomide was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. Lenalidomide, sold under the trade name Revlimid among others.....
SynopsisThe global market for Dry Eye Drugs was valued at US$ 10740 million in the year 2024 and is projected to reach a revised size of US$ 23500 million by 2031, growing at a CAGR of 12.0% during the forecast period. Dry eye syndrome (DES), also known as kerat.....
SynopsisThe global market for Therapeutic Enzymes was valued at US$ 9390 million in the year 2024 and is projected to reach a revised size of US$ 20660 million by 2031, growing at a CAGR of 12.1% during the forecast period. Therapeutic enzymes have a broad varie.....
SynopsisThe global market for Antihypertensive Beta Blockers was valued at US$ 18500 million in the year 2024 and is projected to reach a revised size of US$ 24340 million by 2031, growing at a CAGR of 4.0% during the forecast period. Antihypertensive beta block.....
SynopsisThe global market for Digoxin was valued at US$ 63.8 million in the year 2024 and is projected to reach a revised size of US$ 78.7 million by 2031, growing at a CAGR of 3.1% during the forecast period. Digoxin is a cardiac glycoside extracted from the le.....
SynopsisThe global market for 3D Reconstructed Corneal Model was valued at US$ 23.5 million in the year 2024 and is projected to reach a revised size of US$ 65.6 million by 2031, growing at a CAGR of 15.8% during the forecast period. 3D Reconstructed Corneal Mod.....
SynopsisThe global market for High-Throughput POCT Molecular Diagnostics Devices was valued at US$ 8700 million in the year 2024 and is projected to reach a revised size of US$ 10340 million by 2031, growing at a CAGR of 2.5% during the forecast period. High-Thr.....
